“Trade Matters” For BRICS In Africa, So Does Internet Connectivity

publicForumLogo 2014

Last week’s World Trade Organization Public Forum hosted dozens of panels on the general theme of “why trade matters.” A panel focusing on the role of Brazil, Russia, India, China and South Africa (BRICS) found that the new BRICS Development Bank could foster infrastructure development in Africa, while another panel said that removing barriers to internet connectivity is key to economic growth.

Nagoya Protocol Enters Into Force, Will Be Tested In Months To Come

Rain Forest - Flickr - Sue Bowen

The Nagoya Protocol, a treaty expected to ensure greater access to genetic resources and a mandatory fair benefit-sharing of the benefits that could be derived from those resources, will enter into force on 12 October, almost four years after it was agreed.

Protect Your Ideas – Top Ways To Guard Your Intellectual Property

With the ever-increasing ease in which information can spread, it is becoming harder to secure your intellectual property or product ideas and ensure they are not unfairly recreated or produced by someone else. Whether you are a small start-up or a multinational organisation, taking steps to protect your intellectual property should be a priority within your business.

Tech Industry Report Ranks Countries On Protectionism – Including IPR

Trade - Flickr - Corey Seeman

A report released today by an American technology industry group ranks countries on the basis of mercantilist policies, urging the United States and multilateral organisations to issue a “bold response” to these restrictive and anti-competitive practices – including intellectual property theft and compulsory licensing permitted under WTO rules in developing countries. The top targets? China and India.

Alarm Over Monsanto-Backed Push To Acquire African Seed Company

Maize seeds - Flickr - Ian Hayhurst

An African civil society group has voiced concerns about the takeover by giant multinational seed companies of home-grown African seed companies, the latest of which involves Africa’s SeedCo.

IP Increasingly Seen As Enabler For Innovation Finance, IP Offices Say

mark-tuminello-finance-innovation

“Intellectual property is a substantial chunk of business investment,” Tony Clayton, chief economist in the United Kingdom IP Office, told a side gathering at the recent World Intellectual Property Organization General Assembly. “It really does matter.”

Formal IP System Does Not Fit Africa, LDCs Need Technological Capacity, Speakers Say

Tobias Schonwetter

On the last day of the World Trade Organization Public Forum, a panel discussed the relationship between intellectual property and innovation in Africa, in particular in the informal sector. The formal IP system does not seems to fit, and least-developed countries need a sound technological base to be able to use the IP system. Separately, a European Patent Office study shows that Africa has a vast yet untapped potential in renewable energy.

Global Value Chains In Africa: Set Of Preconditions Needed To Be Profitable, Panel Says

Susan Bingi address WTO Public Forum

At the World Trade Organization Public Forum last week, a panel explored opportunities for Africa in global and regional value chains. A certain level of development needs to be achieved so that countries can benefit from global value chains, speakers said.

Right Of Reply To IP-Watch Article: ‘EPO Internal Strife Spills Over Into European Parliament, Human Rights Court’

EPO logo

This letter is published under the legal right of reply of an individual referenced in a previous article published in Intellectual Property Watch. It is published upon her request.

At WTO, Experts Discuss Solutions To Drugs Innovation Crisis; IP Not In The List

Panellists at UAEM event

The Universities Allied for Essential Medicines (UAEM) organised a panel at the World Trade Organization Public Forum this week on new approaches in university management of intellectual property. The panel gathered a diverse panel of experts giving their take on possible solutions to less innovation and higher prices of drugs, and the role of publicly-funded research.